Lukas RV - Search Results

1

A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.

Kumthekar P, Lyleroehr M, Lacson L, Lukas RV, Dixit K, Stupp R, Kruser T, Raizer J, Hou A, Sachdev S, Schwartz M, Pa JB, Lezon R, Schmidt K, Amidei C, Kaiser K. Kumthekar P, et al. Among authors: lukas rv. BMC Cancer. 2024 Apr 25;24(1):527. doi: 10.1186/s12885-024-12042-x. BMC Cancer. 2024. PMID: 38664630 Free PMC article.

2

Education research: case logs in the assessment of medical students in the neurology outpatient clinic.

Albert DV, Brorson JR, Amidei C, Lukas RV. Albert DV, et al. Among authors: lukas rv. Neurology. 2014 Apr 22;82(16):e138-41. doi: 10.1212/WNL.0000000000000333. Neurology. 2014. PMID: 24753516 Free PMC article.

3

Clinical neuro-oncology formal education opportunities for medical students in the United States and Canada.

Dixit KS, Nicholas MK, Lukas RV. Dixit KS, et al. Among authors: lukas rv. World Neurosurg. 2014 Dec;82(6):938-44. doi: 10.1016/j.wneu.2014.05.022. Epub 2014 May 13. World Neurosurg. 2014. PMID: 24834873

4

Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.

Lukas RV, Amidei C. Lukas RV, et al. Tumori. 2014 May-Jun;100(3):358-62. doi: 10.1700/1578.17228. Tumori. 2014. PMID: 25076251 Review.

5

Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.

Lukas RV, Kumthekar P, Rizvi S, Salgia R. Lukas RV, et al. Future Oncol. 2016;12(8):1045-58. doi: 10.2217/fon.16.17. Epub 2016 Feb 18. Future Oncol. 2016. PMID: 26888310 Review.

6

Tumor Treating Fields in Neuro-Oncological Practice.

Mrugala MM, Ruzevick J, Zlomanczuk P, Lukas RV. Mrugala MM, et al. Among authors: lukas rv. Curr Oncol Rep. 2017 Aug;19(8):53. doi: 10.1007/s11912-017-0611-8. Curr Oncol Rep. 2017. PMID: 28664468 Review.

7

Skin toxicities associated with tumor treating fields: case based review.

Lukas RV, Ratermann KL, Wong ET, Villano JL. Lukas RV, et al. J Neurooncol. 2017 Dec;135(3):593-599. doi: 10.1007/s11060-017-2612-8. Epub 2017 Aug 28. J Neurooncol. 2017. PMID: 28849343

8

Hospital volume and group expertise in newly diagnosed glioblastoma management.

Lukas RV, Lesniak MS, Stupp R. Lukas RV, et al. J Neurooncol. 2018 Jan;136(1):213-214. doi: 10.1007/s11060-017-2632-4. Epub 2017 Oct 7. J Neurooncol. 2018. PMID: 28988378 No abstract available.

9

State-of-the-art considerations in small cell lung cancer brain metastases.

Lukas RV, Gondi V, Kamson DO, Kumthekar P, Salgia R. Lukas RV, et al. Oncotarget. 2017 Jul 18;8(41):71223-71233. doi: 10.18632/oncotarget.19333. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050358 Free PMC article. Review.

10

IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma.

Ladomersky E, Zhai L, Lenzen A, Lauing KL, Qian J, Scholtens DM, Gritsina G, Sun X, Liu Y, Yu F, Gong W, Liu Y, Jiang B, Tang T, Patel R, Platanias LC, James CD, Stupp R, Lukas RV, Binder DC, Wainwright DA. Ladomersky E, et al. Among authors: lukas rv. Clin Cancer Res. 2018 Jun 1;24(11):2559-2573. doi: 10.1158/1078-0432.CCR-17-3573. Epub 2018 Mar 2. Clin Cancer Res. 2018. PMID: 29500275 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page